Cargando…
The role of EGFR double minutes in modulating the response of malignant gliomas to radiotherapy
EGFR amplification in cells having double minute chromosomes (DM) is commonly found in glioblastoma multiforme (GBM); however, how much it contributes to the current failure to treat GBM successfully is unknown. We studied two syngeneic primary cultures derived from a GBM with and without cells carr...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655244/ https://www.ncbi.nlm.nih.gov/pubmed/29113349 http://dx.doi.org/10.18632/oncotarget.20714 |
_version_ | 1783273495548919808 |
---|---|
author | Zhou, Yi-Hong Chen, Yumay Hu, Yuanjie Yu, Liping Tran, Katherine Giedzinski, Erich Ru, Ning Gau, Alex Pan, Francine Qiao, Jiao Atkin, Naomi Ly, Khang Chi Lee, Nathan Siegel, Eric R. Linskey, Mark E. Wang, Ping Limoli, Charles |
author_facet | Zhou, Yi-Hong Chen, Yumay Hu, Yuanjie Yu, Liping Tran, Katherine Giedzinski, Erich Ru, Ning Gau, Alex Pan, Francine Qiao, Jiao Atkin, Naomi Ly, Khang Chi Lee, Nathan Siegel, Eric R. Linskey, Mark E. Wang, Ping Limoli, Charles |
author_sort | Zhou, Yi-Hong |
collection | PubMed |
description | EGFR amplification in cells having double minute chromosomes (DM) is commonly found in glioblastoma multiforme (GBM); however, how much it contributes to the current failure to treat GBM successfully is unknown. We studied two syngeneic primary cultures derived from a GBM with and without cells carrying DM, for their differential molecular and metabolic profiles, in vivo growth patterns, and responses to irradiation (IR). Each cell line has a distinct molecular profile consistent with an invasive “go” (with DM) or angiogenic “grow” phenotype (without DM) demonstrated in vitro and in intracranial xenograft models. Cells with DM were relatively radio-resistant and used higher glycolytic respiration and lower oxidative phosphorylation in comparison to cells without them. The DM-containing cell was able to restore tumor heterogeneity by mis-segregation of the DM-chromosomes, giving rise to cell subpopulations without them. As a response to IR, DM-containing cells switched their respiration from glycolic metabolism to oxidative phosphorylation and shifted molecular profiles towards that of cells without DM. Irradiated cells with DM showed the capacity to alter their extracellular microenvironment to not only promote invasiveness of the surrounding cells, regardless of DM status, but also to create a pro-angiogenic tumor microenvironment. IR of cells without DM was found primarily to increase extracellular MMP2 activity. Overall, our data suggest that the DM-containing cells of GBM are responsible for tumor recurrence due to their high invasiveness and radio-resistance and the mis-segregation of their DM chromosomes, to give rise to fast-growing cells lacking DM chromosomes. |
format | Online Article Text |
id | pubmed-5655244 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-56552442017-11-06 The role of EGFR double minutes in modulating the response of malignant gliomas to radiotherapy Zhou, Yi-Hong Chen, Yumay Hu, Yuanjie Yu, Liping Tran, Katherine Giedzinski, Erich Ru, Ning Gau, Alex Pan, Francine Qiao, Jiao Atkin, Naomi Ly, Khang Chi Lee, Nathan Siegel, Eric R. Linskey, Mark E. Wang, Ping Limoli, Charles Oncotarget Research Paper EGFR amplification in cells having double minute chromosomes (DM) is commonly found in glioblastoma multiforme (GBM); however, how much it contributes to the current failure to treat GBM successfully is unknown. We studied two syngeneic primary cultures derived from a GBM with and without cells carrying DM, for their differential molecular and metabolic profiles, in vivo growth patterns, and responses to irradiation (IR). Each cell line has a distinct molecular profile consistent with an invasive “go” (with DM) or angiogenic “grow” phenotype (without DM) demonstrated in vitro and in intracranial xenograft models. Cells with DM were relatively radio-resistant and used higher glycolytic respiration and lower oxidative phosphorylation in comparison to cells without them. The DM-containing cell was able to restore tumor heterogeneity by mis-segregation of the DM-chromosomes, giving rise to cell subpopulations without them. As a response to IR, DM-containing cells switched their respiration from glycolic metabolism to oxidative phosphorylation and shifted molecular profiles towards that of cells without DM. Irradiated cells with DM showed the capacity to alter their extracellular microenvironment to not only promote invasiveness of the surrounding cells, regardless of DM status, but also to create a pro-angiogenic tumor microenvironment. IR of cells without DM was found primarily to increase extracellular MMP2 activity. Overall, our data suggest that the DM-containing cells of GBM are responsible for tumor recurrence due to their high invasiveness and radio-resistance and the mis-segregation of their DM chromosomes, to give rise to fast-growing cells lacking DM chromosomes. Impact Journals LLC 2017-09-08 /pmc/articles/PMC5655244/ /pubmed/29113349 http://dx.doi.org/10.18632/oncotarget.20714 Text en Copyright: © 2017 Zhou et al. http://creativecommons.org/licenses/by/3.0/ This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) (CC-BY), which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Research Paper Zhou, Yi-Hong Chen, Yumay Hu, Yuanjie Yu, Liping Tran, Katherine Giedzinski, Erich Ru, Ning Gau, Alex Pan, Francine Qiao, Jiao Atkin, Naomi Ly, Khang Chi Lee, Nathan Siegel, Eric R. Linskey, Mark E. Wang, Ping Limoli, Charles The role of EGFR double minutes in modulating the response of malignant gliomas to radiotherapy |
title | The role of EGFR double minutes in modulating the response of malignant gliomas to radiotherapy |
title_full | The role of EGFR double minutes in modulating the response of malignant gliomas to radiotherapy |
title_fullStr | The role of EGFR double minutes in modulating the response of malignant gliomas to radiotherapy |
title_full_unstemmed | The role of EGFR double minutes in modulating the response of malignant gliomas to radiotherapy |
title_short | The role of EGFR double minutes in modulating the response of malignant gliomas to radiotherapy |
title_sort | role of egfr double minutes in modulating the response of malignant gliomas to radiotherapy |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655244/ https://www.ncbi.nlm.nih.gov/pubmed/29113349 http://dx.doi.org/10.18632/oncotarget.20714 |
work_keys_str_mv | AT zhouyihong theroleofegfrdoubleminutesinmodulatingtheresponseofmalignantgliomastoradiotherapy AT chenyumay theroleofegfrdoubleminutesinmodulatingtheresponseofmalignantgliomastoradiotherapy AT huyuanjie theroleofegfrdoubleminutesinmodulatingtheresponseofmalignantgliomastoradiotherapy AT yuliping theroleofegfrdoubleminutesinmodulatingtheresponseofmalignantgliomastoradiotherapy AT trankatherine theroleofegfrdoubleminutesinmodulatingtheresponseofmalignantgliomastoradiotherapy AT giedzinskierich theroleofegfrdoubleminutesinmodulatingtheresponseofmalignantgliomastoradiotherapy AT runing theroleofegfrdoubleminutesinmodulatingtheresponseofmalignantgliomastoradiotherapy AT gaualex theroleofegfrdoubleminutesinmodulatingtheresponseofmalignantgliomastoradiotherapy AT panfrancine theroleofegfrdoubleminutesinmodulatingtheresponseofmalignantgliomastoradiotherapy AT qiaojiao theroleofegfrdoubleminutesinmodulatingtheresponseofmalignantgliomastoradiotherapy AT atkinnaomi theroleofegfrdoubleminutesinmodulatingtheresponseofmalignantgliomastoradiotherapy AT lykhangchi theroleofegfrdoubleminutesinmodulatingtheresponseofmalignantgliomastoradiotherapy AT leenathan theroleofegfrdoubleminutesinmodulatingtheresponseofmalignantgliomastoradiotherapy AT siegelericr theroleofegfrdoubleminutesinmodulatingtheresponseofmalignantgliomastoradiotherapy AT linskeymarke theroleofegfrdoubleminutesinmodulatingtheresponseofmalignantgliomastoradiotherapy AT wangping theroleofegfrdoubleminutesinmodulatingtheresponseofmalignantgliomastoradiotherapy AT limolicharles theroleofegfrdoubleminutesinmodulatingtheresponseofmalignantgliomastoradiotherapy AT zhouyihong roleofegfrdoubleminutesinmodulatingtheresponseofmalignantgliomastoradiotherapy AT chenyumay roleofegfrdoubleminutesinmodulatingtheresponseofmalignantgliomastoradiotherapy AT huyuanjie roleofegfrdoubleminutesinmodulatingtheresponseofmalignantgliomastoradiotherapy AT yuliping roleofegfrdoubleminutesinmodulatingtheresponseofmalignantgliomastoradiotherapy AT trankatherine roleofegfrdoubleminutesinmodulatingtheresponseofmalignantgliomastoradiotherapy AT giedzinskierich roleofegfrdoubleminutesinmodulatingtheresponseofmalignantgliomastoradiotherapy AT runing roleofegfrdoubleminutesinmodulatingtheresponseofmalignantgliomastoradiotherapy AT gaualex roleofegfrdoubleminutesinmodulatingtheresponseofmalignantgliomastoradiotherapy AT panfrancine roleofegfrdoubleminutesinmodulatingtheresponseofmalignantgliomastoradiotherapy AT qiaojiao roleofegfrdoubleminutesinmodulatingtheresponseofmalignantgliomastoradiotherapy AT atkinnaomi roleofegfrdoubleminutesinmodulatingtheresponseofmalignantgliomastoradiotherapy AT lykhangchi roleofegfrdoubleminutesinmodulatingtheresponseofmalignantgliomastoradiotherapy AT leenathan roleofegfrdoubleminutesinmodulatingtheresponseofmalignantgliomastoradiotherapy AT siegelericr roleofegfrdoubleminutesinmodulatingtheresponseofmalignantgliomastoradiotherapy AT linskeymarke roleofegfrdoubleminutesinmodulatingtheresponseofmalignantgliomastoradiotherapy AT wangping roleofegfrdoubleminutesinmodulatingtheresponseofmalignantgliomastoradiotherapy AT limolicharles roleofegfrdoubleminutesinmodulatingtheresponseofmalignantgliomastoradiotherapy |